- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-227262, 333-217419, 333-213627 and 333-201708), the Registration Statements on Form S-3 (Nos. 333-229459, 333-220012, 333-213635, 333-212015 and 333-209026) and the Registration Statements on Form S-1 (Nos. 333-221686 and 333-221027) of BioPharmX Corporation of our report (which contains an explanatory paragraph relating to BioPharmX Corporation’s ability to continue as a going concern as described in Note 2 to the consolidated financial statements) dated March 14, 2019 relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K.
/s/ BPM LLP
San Jose, California
March 14, 2019